The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1

26Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Background: MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. Methods: Using RT-PCR, immunoblots invasion assays and bioinformatics strategies, we investigated the potential role of miR-325 in HCC. Results: We showed that miR-325 was decreased and HMGB1 was increased in 99 patients with hepatocellular carcinoma. MiR-325 inhibition promoted cell invasion and proliferation, while miR-325 upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. We further showed that HMGB1 might be a direct target of miR-325 and is negatively regulated by miR-325. Down-regulation of miR-325 predicts poor prognosis for HCC patients. Conclusions: These findings implied that miR-325 regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for HCC. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4655707031717989

Cite

CITATION STYLE

APA

Li, H., Huang, W., & Luo, R. (2015, July 22). The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1. Diagnostic Pathology. BioMed Central Ltd. https://doi.org/10.1186/s13000-015-0323-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free